Chronic Psychosocial Stress Exacerbates Impairment of Cognition and Long-Term Potentiation in β-Amyloid Rat Model of Alzheimer's Disease

Biological Psychiatry

Volumn 65, Issue 11, 2009, Pages 918-926

  Srivareerat, Marisa ^a   Tran, Trinh T ^a   Alzoubi, Karem H ^b   Alkadhi, Karim A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

A 1 42; Area CA1; beta amyloid (A ) rat model of AD; CaMKII; hippocampus; radial arm water maze

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUCOCORTICOID RECEPTOR;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; CALCIUM CURRENT; CHRONIC STRESS; COGNITIVE DEFECT; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; HORMONE RECEPTOR INTERACTION; IMMUNOBLOTTING; LEARNING; LONG TERM EXPOSURE; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; NERVE CELL PLASTICITY; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SOCIAL STRESS; STRESS; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BIOPHYSICS; CALCINEURIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

EID: 65149084973     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.08.021     Document Type: Article

References (72)

1. Masters C.L., and Beyreuther K. Science, medicine and the future: Alzheimer's disease. BMJ 316 (1998) 446-448
2. Iqbal K., and Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: Significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12 (2008) 38-55
3. Nitta A., Itoh A., Hasegawa T., and Nabeshima T. Beta-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 170 (1994) 63-66
4. Tanzi R.E. The synaptic Abeta hypothesis of Alzheimer disease. Nat Neurosci 8 (2005) 977-979
5. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: Bridging the gap between plaques and tangles. Neuron 24 (1999) 521-529
6. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
7. Rowan M.J., Klyubin I., Cullen W.K., and Anwyl R. Synaptic plasticity in animal models of early Alzheimer's disease. Philos Trans R Soc Lond B Biol Sci 358 (2003) 821-828
8. Kim J.J., Foy M.R., and Thompson R.F. Behavioral stress modifies hippocampal plasticity through N-methyl-D-aspartate receptor activation. Proc Natl Acad Sci U S A 93 (1996) 4750-4753
9. Vanitallie T.B. Stress: A risk factor for serious illness. Metabolism 51 (2002) 40-45
10. Starkman M.N., Giordani B., Gebarski S.S., Berent S., Schork M.A., and Schteingart D.E. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 46 (1999) 1595-1602
11. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry 62 suppl 17 (2001) 41-46
12. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci 22 (1999) 105-122
13. Meyer S.E., Chrousos G.P., and Gold P.W. Major depression and the stress system: A life span perspective. Dev Psychopathol 13 (2001) 565-580
14. Gerges N.Z., Alzoubi K.H., Park C.R., Diamond D.M., and Alkadhi K.A. Adverse effect of the combination of hypothyroidism and chronic psychosocial stress on hippocampus-dependent memory in rats. Behav Brain Res 155 (2004) 77-84
15. Joels M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol Sci 27 (2006) 244-250
16. Luine V., Martinez C., Villegas M., Magarinos A.M., and McEwen B.S. Restraint stress reversibly enhances spatial memory performance. Physiol Behav 59 (1996) 27-32
17. Sandi C. Stress, cognitive impairment and cell adhesion molecules. Nat Rev Neurosci 5 (2004) 917-930
18. Aleisa A.M., Alzoubi K.H., Gerges N.Z., and Alkadhi K.A. Chronic psychosocial stress-induced impairment of hippocampal LTP: Possible role of BDNF. Neurobiol Dis 22 (2006) 453-462
19. Kim J.J., and Diamond D.M. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3 (2002) 453-462
20. Gerges N.Z., Stringer J.L., and Alkadhi K.A. Combination of hypothyroidism and stress abolishes early LTP in the CA1 but not dentate gyrus of hippocampus of adult rats. Brain Res 922 (2001) 250-260
21. Aleisa A.M., Alzoubi K.H., Gerges N.Z., and Alkadhi K.A. Nicotine blocks stress-induced impairment of spatial memory and long-term potentiation of the hippocampal CA1 region. Int J Neuropsychopharmacol 9 (2006) 417-426
22. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J Med 338 (1998) 171-179
23. Kurukulasuriya R., Sorensen B.K., Link J.T., Patel J.R., Jae H.S., Winn M.X., et al. Biaryl amide glucagon receptor antagonists. Bioorg Med Chem Lett 14 (2004) 2047-2050
24. Landfield P.W., Blalock E.M., Chen K.C., and Porter N.M. A new glucocorticoid hypothesis of brain aging: Implications for Alzheimer's disease. Curr Alzheimer Res 4 (2007) 205-212
25. Pedersen W.A., Wan R., and Mattson M.P. Impact of aging on stress-responsive neuroendocrine systems. Mech Ageing Dev 122 (2001) 963-983
26. Alkadhi K.A., Alzoubi K.H., Aleisa A.M., Tanner F.L., and Nimer A.S. Psychosocial stress-induced hypertension results from in vivo expression of long-term potentiation in rat sympathetic ganglia. Neurobiol Dis 20 (2005) 849-857
27. Nabeshima T., Ogawa S., Ishimaru H., Kameyama T., Fukuta T., Takeuchi R., and Hayashi K. Memory impairment and morphological changes in rats induced by active fragment of anti-nerve growth factor-antibody. Biochem Biophys Res Commun 175 (1991) 215-219
28. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd Edition (1986), Academic Press Inc, New York
29. Diamond D.M., Park C.R., Heman K.L., and Rose G.M. Exposing rats to a predator impairs spatial working memory in the radial arm water maze. Hippocampus 9 (1999) 542-552
30. Alzoubi K.H., Gerges N.Z., and Alkadhi K.A. Levothyroxin restores hypothyroidism-induced impairment of LTP of hippocampal CA1: Electrophysiological and molecular studies. Exp Neurol 195 (2005) 330-341
31. Aleisa A.M., Alzoubi K.H., and Alkadhi K.A. Nicotine prevents stress-induced enhancement of long-term depression in hippocampal area CA1: Electrophysiological and molecular studies. J Neurosci Res 83 (2006) 309-317
32. Gerges N.Z., Aleisa A.M., Schwarz L.A., and Alkadhi K.A. Reduced basal CaMKII levels in hippocampal CA1 region: Possible cause of stress-induced impairment of LTP in chronically stressed rats. Hippocampus 14 (2004) 402-410
33. Alzoubi K.H., Aleisa A.M., and Alkadhi K.A. Molecular studies on the protective effect of nicotine in adult-onset hypothyroidism-induced impairment of long-term potentiation. Hippocampus 16 (2006) 861-874
34. Bliss T.V., and Collingridge G.L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
35. Giese K.P., Fedorov N.B., Filipkowski R.K., and Silva A.J. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science 279 (1998) 870-873
36. Lisman J., Schulman H., and Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3 (2002) 175-190
37. Stephan A., and Phillips A.G. A case for a non-transgenic animal model of Alzheimer's disease. Genes Brain Behav 4 (2005) 157-172
38. Chen S.Y., Wright J.W., and Barnes C.D. The neurochemical and behavioral effects of beta-amyloid peptide (25-35). Brain Res 720 (1996) 54-60
39. Nitta A., Fukuta T., Hasegawa T., and Nabeshima T. Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol 73 (1997) 51-57
40. Nakamura S., Murayama N., Noshita T., Annoura H., and Ohno T. Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res 912 (2001) 128-136
41. O'Hare E., Weldon D.T., Mantyh P.W., Ghilardi J.R., Finke M.P., Kuskowski M.A., et al. Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42). Brain Res 815 (1999) 1-10
42. Terranova J.P., Kan J.P., Storme J.J., Perreaut P., Le Fur G., and Soubrie P. Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: Reversal by SR 57746A, a non-peptide neurotrophic compound. Neurosci Lett 213 (1996) 79-82
43. Nabeshima T., and Nitta A. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. Tohoku J Exp Med 174 (1994) 241-249
44. Yankner B.A., Caceres A., and Duffy L.K. Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A 87 (1990) 9020-9023
45. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359 (1992) 325-327
46. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258 (1992) 126-129
47. Jarrett J.T., and Lansbury Jr. P.T. Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73 (1993) 1055-1058
48. Jarrett J.T., and Lansbury Jr. P.T. Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31 (1992) 12345-12352
49. Snyder S.W., Ladror U.S., Wade W.S., Wang G.T., Barrett L.W., Matayoshi E.D., et al. Amyloid-beta aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J 67 (1994) 1216-1228
50. Nabeshima T., and Nitta A. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. Tohoku J Exp Med 174 (1994) 241-249
51. Stephan A., Laroche S., and Davis S. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21 (2001) 5703-5714
52. Kotilinek L.A., Bacskai B., Westerman M., Kawarabayashi T., Younkin L., Hyman B.T., et al. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci 22 (2002) 6331-6335
53. Malenka R.C., and Nicoll R.A. Long-term potentiation-a decade of progress?. Science 285 (1999) 1870-1874
54. Malinow R., Schulman H., and Tsien R.W. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science 245 (1989) 862-866
55. Fukunaga K., Muller D., and Miyamoto E. CaM kinase II in long-term potentiation. Neurochem Int 28 (1996) 343-358
56. Nayak A.S., Moore C.I., and Browning M.D. Ca2+/calmodulin-dependent protein kinase II phosphorylation of the presynaptic protein synapsin I is persistently increased during long-term potentiation. Proc Natl Acad Sci U S A 93 (1996) 15451-15456
57. Magarinos A.M., and McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69 (1995) 89-98
58. Pavlides C., Watanabe Y., Magarinos A.M., and McEwen B.S. Opposing roles of type I and type II adrenal steroid receptors in hippocampal long-term potentiation. Neuroscience 68 (1995) 387-394
59. Conrad C.D., Lupien S.J., and McEwen B.S. Support for a bimodal role for type II adrenal steroid receptors in spatial memory. Neurobiol Learn Mem 72 (1999) 39-46
60. Dong H., Goico B., Martin M., Csernansky C.A., Bertchume A., and Csernansky J.G. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127 (2004) 601-609
61. Liu F., Grundke-Iqbal I., Iqbal K., Oda Y., Tomizawa K., and Gong C.X. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 280 (2005) 37755-37762
62. Liang Z., Liu F., Grundke-Iqbal I., Iqbal K., and Gong C.X. Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J Neurochem 103 (2007) 2462-2470
63. Knobloch M., Farinelli M., Konietzko U., Nitsch R.M., and Mansuy I.M. Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J Neurosci 27 (2007) 7648-7653
64. Zhao D., Watson J.B., and Xie C.W. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. J Neurophysiol 92 (2004) 2853-2858
65. Wang J.H., and Kelly P.T. Postsynaptic calcineurin activity downregulates synaptic transmission by weakening intracellular Ca2+ signaling mechanisms in hippocampal CA1 neurons. J Neurosci 17 (1997) 4600-4611
66. Green K.N., Billings L.M., Roozendaal B., McGaugh J.L., and LaFerla F.M. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26 (2006) 9047-9056
67. Jeong Y.H., Park C.H., Yoo J., Shin K.Y., Ahn S.M., Kim H.S., Lee S.H., Emson P.C., and Suh Y.H. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. Faseb J 20 (2006) 729-731
68. Kang J.E., Cirrito J.R., Dong H., Csernansky J.G., and Holtzman D.M. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc Natl Acad Sci U S A 104 (2007) 10673-10678
69. Peavy G.M., Lange K.L., Salmon D.P., Patterson T.L., Goldman S., Gamst A.C., et al. The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol Psychiatry 62 (2007) 472-478
70. Walton M., Henderson C., Mason-Parker S., Lawlor P., Abraham W.C., Bilkey D., and Dragunow M. Immediate early gene transcription and synaptic modulation. J Neurosci Res 58 (1999) 96-106
71. Stephan A., Laroche S., and Davis S. Learning deficits and dysfunctional synaptic plasticity induced by aggregated amyloid deposits in the dentate gyrus are rescued by chronic treatment with indomethacin. Eur J Neurosci 17 (2003) 1921-1927
72. Trubetskaya V.V., Stepanichev M.Y., Onufriev M.V., Lazareva N.A., Markevich V.A., and Gulyaeva N.V. Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo. Neurosci Behav Physiol 33 (2003) 95-98